Lurbinectedin Market Size
The global Lurbinectedin market size was valued at USD 350.00 million in 2025 and is expected to reach USD 6,953.33 million by 2033, at a CAGR of 45.30% during the forecast period
The market growth is primarily driven by the rising prevalence of small cell lung cancer and increasing adoption of targeted oncology therapies, as Lurbinectedin gains traction as an important treatment option in second-line cancer care
𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -
Furthermore, expanding regulatory approvals, growing clinical research activities, and the shift toward precision medicine in oncology are strengthening the demand for Lurbinectedin, thereby significantly accelerating the overall market expansion
1 次瀏覽